The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
本发明涉及化合物,其中包含
2,3-二苯基喹喔啉基团,该基团能够抑制Akt,一种
丝氨酸/苏
氨酸蛋白激酶的活性。本发明还涉及包含本发明化合物的化疗组合物以及治疗癌症的方法,包括给予本发明化合物的治疗方法。